Raymond James Trust’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,932
Closed -$177K 1269
2024
Q1
$177K Sell
21,932
-6,762
-24% -$59.8K ﹤0.01% 1203
2023
Q4
$285K Buy
28,694
+68
+0.2% +$534 0.01% 944
2023
Q3
$229K Buy
28,626
+482
+2% +$4.84K 0.01% 1019
2023
Q2
$309K Buy
28,144
+368
+1% +$3.79K 0.01% 882
2023
Q1
$287K Buy
27,776
+5,580
+25% +$65.7K 0.01% 888
2022
Q4
$244K Buy
22,196
+5,969
+37% +$76.7K 0.01% 941
2022
Q3
$252K Buy
16,227
+1,084
+7% +$23.8K 0.01% 867
2022
Q2
$347K Buy
15,143
+3,158
+26% +$67.6K 0.01% 735
2022
Q1
$296K Buy
+11,985
New +$271K 0.01% 888

Other funds holding DH

Raymond James Trust's DH Position: Q2 2024 in Review

Raymond James Trust sold out of Definitive Healthcare (DH) in Q2 2024, closing a stake of 21,932 shares — an estimated $177K sold.

Raymond James Trust first reported a position in DH in Q1 2022 and held it in 9 quarters. The position peaked at $347K in Q2 2022. 143 funds tracked by Wall St. Rank hold DH as of Q2 2024.

  • Raymond James Trust reported no remaining Definitive Healthcare position as of Q2 2024 after selling out during the quarter.
  • Raymond James Trust sold 21,932 Definitive Healthcare shares in Q2 2024, an estimated $177K.
  • Raymond James Trust first reported a position in Definitive Healthcare in Q1 2022 and held it in 9 quarters.
  • Raymond James Trust's Definitive Healthcare position peaked at $347K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2024.

Based on Raymond James Trust's 13F filing for Q2 2024, filed 25 Jul 2024.